Form 8-K - Current report:
SEC Accession No. 0001576280-26-000004
Filing Date
2026-01-12
Accepted
2026-01-12 06:04:59
Documents
14
Period of Report
2026-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gh-20260111.htm   iXBRL 8-K 30934
2 EX-99.1 gh-01122026xexhibit991.htm EX-99.1 26927
6 guardantlogoa01.gif GRAPHIC 17260
  Complete submission text file 0001576280-26-000004.txt   202953

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20260111.xsd EX-101.SCH 1882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20260111_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20260111_pre.xml EX-101.PRE 12605
16 EXTRACTED XBRL INSTANCE DOCUMENT gh-20260111_htm.xml XML 2798
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 26524533
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)